Legit · Who Owns It

Who Owns COSRX? Inside Amorepacific's Quiet Takeover of a K-Beauty Cult Brand

A dermatology-obsessed startup built its name on snail mucin and low-pH acids. A 79-year-old family conglomerate bought it, slice by slice, until it owned almost all of it. Here's the real chain of ownership.

AntCode
Photo: Wikimedia Commons (CC0)
By Nari Yoon · K-Beauty Desk · Reported feature
Updated August 2026 · 9 min read
Honest disclosure: DopamineKart has no business relationship with Amorepacific or COSRX. Nothing in this piece is sponsored, and no affiliate links appear in the ownership history below. Where we link out to COSRX or Amorepacific's own products elsewhere on this site, those are separate, clearly marked pages.

If you've bought a snail mucin essence in the last five years, there's a good chance it was COSRX's. The brand turned an unglamorous idea — that a mollusk's slime filtrate could calm irritated skin — into one of the most recognizable names to come out of Korea's skincare boom. What a lot of shoppers don't know is that COSRX hasn't been an independent company for a while. It's now a subsidiary of Amorepacific, the same conglomerate behind Sulwhasoo, Innisfree, Laneige, and roughly two dozen other beauty brands. The takeover happened in stages, over several years, and it's a useful case study in how Korea's beauty giants actually grow: not by building everything in-house, but by buying the startups that get somewhere first.

The dermatology side-project that became COSRX

COSRX was formally established in December 2013 by Jun Sang-hun, whose background was in cosmetic product development rather than marketing. The name is a portmanteau — "cosmetics" plus "Rx," the prescription symbol — meant to signal a clinical, ingredient-first approach rather than a beauty-counter one. The brand built its identity around a short list of specific, unglamorous products instead of a sprawling catalog: the Advanced Snail 96 Mucin Power Essence, the low-pH BHA Blackhead Power Liquid, and a run of Centella Asiatica-based calming formulas aimed at reactive, acne-prone, or over-exfoliated skin.

That narrowness is part of why it traveled so well. COSRX skipped the whimsical branding a lot of K-beauty exports leaned on in the 2010s and marketed itself almost like an ingredient spec sheet — pH numbers on the label, minimal fragrance, active percentages spelled out. It found an audience with skincare forums first, then with a wider wave of shoppers discovering K-beauty through Amazon and, later, TikTok, where the snail mucin essence in particular became a recurring recommendation across skin-of-color and sensitive-skin communities alike.

Drafted by AntCode — Legit editorial desk

The family conglomerate on the other side of the deal

Amorepacific's story starts decades before skincare influencers existed. In the 1930s, a woman named Yun Dok-jeong sold homemade camellia oil in Kaesong, in what is now North Korea. Her son, Suh Sung-hwan, took over and formalized the business in 1945 under the name Taepyeongyang — Korean for "Pacific Ocean." Suh Sung-hwan built it into Korea's dominant cosmetics maker over the following decades. In 1997 he handed control to his son, Suh Kyung-bae, who pushed the company toward multiple distinct sub-brands rather than one house label, and the corporate name changed to Amorepacific in 2002.

That multi-brand strategy is why Amorepacific's portfolio looks the way it does today: separate labels built around separate ingredient stories and separate market positioning, all reporting up to one parent. Sulwhasoo carries the luxury, ginseng-and-herbal-medicine positioning. Innisfree, launched in 2000, is built around Jeju Island ingredients and a "clean, natural" identity. Mamonde leans on flower extracts like camellia and jasmine. Etude House and Laneige each carve out their own lanes. COSRX is the newest and, notably, the only major addition in the group that Amorepacific didn't create from scratch — it bought its way in.

How the takeover actually happened

Amorepacific didn't acquire COSRX outright in one move. It built its position gradually, and the public record of the deal is unusually well documented for a Korean beauty acquisition:

The acquisition was covered by trade outlets including BeautyMatter, Cosmetics Business, and Retail Dive, and formally announced by Amorepacific itself via press release. None of that coverage suggests any deception toward shoppers — Amorepacific has been public about the deal at every stage — but it also wasn't loudly advertised on COSRX's own packaging or storefront, which is part of why so many buyers still think of it as an independent indie brand.

The name on the tube didn't change. The org chart behind it did.

What actually changed after the deal

From a shopper's side, COSRX's product line and branding stayed recognizably itself — same packaging language, same ingredient-forward marketing, same hero products. What changed was distribution muscle and manufacturing scale: as an Amorepacific subsidiary, COSRX gained access to a much larger company's supply chain, regulatory teams, and international retail relationships, which likely explains its continued expansion into markets an independent Korean skincare startup would struggle to enter alone. Founder Jun Sang-hun's day-to-day role in the company following the 2023 ownership transfer hasn't been detailed in public reporting in the same depth as the deal terms themselves — that's a gap worth naming rather than guessing at.

1945Amorepacific's founding, as Taepyeongyang
2013COSRX formally established
2021Amorepacific's first COSRX stake
2023COSRX becomes an Amorepacific subsidiary

Where COSRX sits in Amorepacific's portfolio

Seeing COSRX next to its siblings makes the acquisition logic clearer — it fills a lane (dermatology-adjacent, ingredient-led, younger audience) that none of Amorepacific's older, in-house brands were originally built for.

Acquired, 2021–2023

COSRX

Founded independently in 2013. Built its name on snail mucin, low-pH BHA, and Centella-based calming lines. Now roughly 93% owned by Amorepacific.

In-house, luxury tier

Sulwhasoo

Amorepacific's flagship prestige line, built around ginseng and traditional Korean herbal medicine formulations dating back to the 1960s-era research that predates the Sulwhasoo name itself.

In-house, launched 2000

Innisfree

Positioned around Jeju Island-sourced ingredients — green tea, volcanic clay — and a simpler, younger identity than Sulwhasoo.

In-house, launched 1991

Mamonde

Flower-extract formulations — camellia, lotus, jasmine — one of Amorepacific's older mid-tier lines, still sold primarily across Asia.

In-house

Laneige

Water-science positioning, globally the most widely distributed Amorepacific brand outside Korea today, known for its overnight lip and sleeping mask formats.

In-house

Etude House

Amorepacific's color-cosmetics and youth-market line, historically sold through its own standalone storefronts across Asia.

The takeaway

None of this makes COSRX's products different or worse than they were as an independent brand — the formulas, the low-pH philosophy, and the dermatology-inspired approach haven't visibly shifted. But "who owns it" is a fair question to ask about any beauty brand you're loyal to, K-beauty included, because conglomerate ownership changes what a brand can do — how fast it scales, which markets it enters, whose supply chain it leans on — even when the packaging looks exactly the same. COSRX is now one node in a 30-plus-brand portfolio built by one Korean family over three generations. That's not a scandal. It's just worth knowing before you assume the tube in your bathroom came from a scrappy indie lab.